These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 37102219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Brightening and Improvement of Facial Skin Quality in Healthy Female Subjects With Moderate Hyperpigmentation or Dark Spots and Moderate Facial Aging.
    Serra M, Bohnert K, Narda M, Granger C, Sadick N.
    J Drugs Dermatol; 2018 Dec 01; 17(12):1310-1315. PubMed ID: 30586263
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluating the Safety and Efficacy of a Topical Formulation Containing Epidermal Growth Factor, Tranexamic Acid, Vitamin C, Arbutin, Niacinamide and Other Ingredients as Hydroquinone 4% Alternatives to Improve Hyperpigmentation: A Prospective, Randomized, Controlled Split Face Study.
    Kalasho BD, Minokadeh A, Zhang-Nunes S, Zoumalan RA, Shemirani NL, Waldman AR, Pletzer V, Zoumalan CI.
    J Cosmet Sci; 2020 Dec 01; 71(5):263-290. PubMed ID: 33022197
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An effective hydroquinone alternative for topical skin lightening.
    Draelos ZD, Deliencourt-Godefroy G, Lopes L.
    J Cosmet Dermatol; 2020 Dec 01; 19(12):3258-3261. PubMed ID: 33098161
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone.
    Draelos ZD.
    J Am Acad Dermatol; 2015 Jan 01; 72(1):105-7. PubMed ID: 25440437
    [Abstract] [Full Text] [Related]

  • 10. Dyspigmentation, skin physiology, and a novel approach to skin lightening.
    Draelos Z, Dahl A, Yatskayer M, Chen N, Krol Y, Oresajo C.
    J Cosmet Dermatol; 2013 Dec 01; 12(4):247-53. PubMed ID: 24305422
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
    Bruce S.
    J Drugs Dermatol; 2013 Mar 01; 12(3):S27-31. PubMed ID: 23545930
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Randomized, Investigator-Blinded Comparison of Two Topical Regimens in Fitzpatrick Skin Types III-VI With Moderate to Severe Facial Hyperpigmentation.
    Vanaman Wilson MJ, Jones IT, Bolton J, Larsen L, Wu DC, Goldman MP.
    J Drugs Dermatol; 2017 Nov 01; 16(11):1127-1132. PubMed ID: 29141061
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging.
    Fabi SG, Goldman MP.
    J Drugs Dermatol; 2013 Mar 01; 12(3):S32-7. PubMed ID: 23545931
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ultrasound enhanced skin-lightening effect of vitamin C and niacinamide.
    Hakozaki T, Takiwaki H, Miyamoto K, Sato Y, Arase S.
    Skin Res Technol; 2006 May 01; 12(2):105-13. PubMed ID: 16626384
    [Abstract] [Full Text] [Related]

  • 19. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial.
    Kimball AB, Kaczvinsky JR, Li J, Robinson LR, Matts PJ, Berge CA, Miyamoto K, Bissett DL.
    Br J Dermatol; 2010 Feb 01; 162(2):435-41. PubMed ID: 19845667
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.